liver
highli
perfus
organ
first
filter
blood
come
intestin
thu
liver
particular
prone
becom
involv
bloodborn
infect
apart
socal
hepat
virus
mani
virus
primarili
target
extrahepat
tissu
also
lead
liver
damag
hepat
damag
rang
asymptomat
elev
aminotransferas
fulmin
hepat
failur
depend
viru
host
immun
respons
immun
system
control
infect
poorli
direct
infect
hepatocyt
liver
necrosi
may
occur
situat
appli
patient
sever
immunosuppress
infect
particularli
virul
agent
virus
caus
hemorrhag
fever
altern
liver
cell
may
becom
victim
collater
damag
without
direct
infect
cytolyt
effector
lymphocyt
expand
outsid
liver
recruit
via
liverresid
macrophag
kupffer
cell
present
viral
antigen
polako
et
al
schumann
et
al
type
liver
damag
particularli
associ
respiratori
virus
influenza
viru
howev
sinc
mani
viral
infect
expand
lymphocyt
bystand
mechan
may
affect
liver
often
muralikrishna
et
al
provid
brief
overview
viral
infect
primarili
design
hepat
virus
may
lead
liver
diseas
hepat
complic
overview
larg
focu
hepat
aspect
viral
infect
thu
reader
interest
detail
inform
consult
comprehens
textbook
microbiolog
clinic
infecti
diseas
approxim
travel
develop
world
requir
medic
care
travel
fever
underli
problem
wilson
et
al
physician
evalu
return
travel
frequent
suspect
rare
exot
diagnos
although
exot
diseas
particular
viral
hemorrhag
fever
sever
threat
certain
region
world
liver
diseas
due
exot
infect
ebola
viru
rift
valley
fever
lassa
fever
report
sporad
repres
frequent
health
problem
return
travel
viral
hemorrhag
fever
share
epidemiolog
clinic
featur
caus
rather
similar
liver
patholog
virus
transmit
via
arthropod
vector
virus
caus
small
vessel
damag
multipl
organ
result
overt
hemorrhag
spectrum
diseas
geograph
distribut
list
tabl
much
attent
paid
abnorm
liver
function
alter
hepat
patholog
nevertheless
clinic
signific
liver
diseas
death
liver
failur
rare
complic
except
yellow
fever
dengu
fever
among
top
three
etiolog
agent
account
approxim
febril
ill
travel
wilson
et
al
note
although
malaria
lead
caus
system
febril
ill
worldwid
apart
subsaharan
africa
central
america
travel
return
tropic
subtrop
region
dengu
fever
frequent
malaria
chikungunya
fever
emerg
novel
viru
infect
recent
expand
asia
africa
also
caus
fever
myalgia
arthralgia
skin
rash
increas
number
patient
tabl
viral
hemorrhag
fever
affect
liver
dengu
viru
complex
compris
four
antigen
relat
distinct
flavivirus
term
dengu
viru
serotyp
dengu
virus
transmit
aed
aegypti
mosquito
epidem
endem
outbreak
caus
acut
infect
three
six
day
mosquito
bite
viru
spread
via
bloodstream
among
variou
organ
isol
frequent
liver
sampl
rosen
khin
dengu
viru
infect
usual
caus
flulik
ill
rashdengu
fever
fig
hepatomegali
elev
serum
aminotransferas
usual
mild
common
dengu
viru
infect
wahid
et
al
clinic
sever
diseas
exampl
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
follow
secondari
infect
dengu
viru
differ
serotyp
world
health
organ
issu
new
guidelin
introduc
revis
classif
scheme
consist
follow
categori
dengu
without
warn
sign
dengu
warn
sign
sever
dengu
world
health
organ
howev
reliabl
warn
sign
sever
dengu
dhf
widespread
petechi
hemorrhag
togeth
multipl
organ
damag
dss
mostli
affect
children
age
extens
capillari
leakag
sever
fluid
deplet
lead
hypovolem
shock
untreat
mortal
approach
fatal
case
dhf
liver
enlarg
pale
steatosi
show
multifoc
hemorrhag
laboratori
diagnosi
dengu
viru
infect
done
detect
viral
compon
exampl
pcr
serum
indirectli
serolog
sensit
approach
depend
durat
cours
patient
ill
patient
present
evalu
current
vaccin
dengu
viru
develop
becom
licens
yet
direct
antivir
therapi
avail
dengu
virus
thu
treatment
support
requir
meticul
fluid
manag
intens
care
dss
detail
treatment
summar
recent
guidelin
world
health
organ
chikungunya
arthropodborn
toga
viru
initi
endem
west
africa
next
spread
indian
ocean
island
southeast
asia
charrel
et
al
chikungunya
fever
origin
consid
diseas
tropic
subtrop
region
outbreak
northern
itali
record
rezza
et
al
sinc
chikungunya
infect
becom
export
western
countri
america
caribbean
region
via
intern
travel
note
dengu
zika
virus
transmit
mosquito
vector
chikungunya
thu
virus
cocircul
geograph
region
coinfect
document
transmiss
chikungunya
via
blood
product
report
franc
nurs
infect
exposur
blood
infect
patient
chikungunya
might
also
transmit
inadvert
organ
transplant
sinc
viremia
exceed
high
level
prior
onset
symptom
infect
begin
abruptli
high
fever
symmetr
polyarthralgia
macular
maculopapular
skin
rash
taubitz
et
al
pruritu
bullou
skin
lesion
also
describ
previous
chikungunya
fever
consid
selflimit
diseas
howev
sever
complic
also
compris
acut
viral
hepat
death
report
recent
outbreak
particularli
elderli
patient
year
peopl
preexist
chronic
medic
problem
patient
persist
symptom
variabl
length
time
acut
ill
manifest
includ
arthritisarthralgia
edemat
polyarthr
finger
toe
morn
pain
stiff
sever
tendosynov
clinic
chikungunya
fever
must
differenti
dengu
fever
share
mani
symptom
featur
diagnosi
chikungunya
viru
infect
suspect
patient
acut
onset
fever
polyarthralgia
possibl
exposur
travel
resid
epidemiolog
risk
area
diagnosi
chikungunya
establish
detect
chikungunya
viral
rna
via
realtim
reversetranscript
polymeras
chain
reaction
rtpcr
chikungunya
viru
serolog
panamerican
health
organis
chikungunya
igm
antibodi
becom
detect
elisa
day
onset
symptom
certain
region
simultan
test
dengu
zika
viru
infect
recommend
exist
specif
antivir
therapi
acut
chikungunya
viru
infect
treatment
consist
support
care
includ
rest
fluid
replac
eventu
use
nonsteroid
antiinflammatori
drug
nsaid
acetaminophen
reliev
pain
fever
patient
suspect
dengu
viru
coinfect
nsaid
avoid
patient
becom
afebril
day
order
avoid
bleed
complic
associ
sever
dengu
viru
infect
chikungunya
infect
prevent
vaccin
hanta
virus
exampl
emerg
virus
belong
genu
hantaviru
within
bunyavirida
famili
negativesens
singlestrand
rna
virus
primarili
harbor
rodent
shed
rodent
urin
saliva
fece
viru
inhal
man
aerosol
dri
rodent
excreta
unusu
circumst
transmit
bite
nichol
et
al
hantavirus
exist
multipl
serotyp
worldwid
differ
virul
consid
apathogen
certain
isol
produc
two
distinct
sever
syndrom
human
hanta
viru
cardiopulmonari
syndrom
mostli
due
isol
america
hemorrhag
fever
renal
syndrom
caus
isol
seoul
viru
dobrava
viru
puumala
viru
hantaan
viru
europ
asia
plyusnin
et
al
instanc
patient
hanta
viru
hemorrhag
fever
suffer
sever
acut
hepat
wherea
renal
damag
rather
mild
wong
et
al
chan
et
al
et
al
hanta
viru
also
incrimin
potenti
caus
cryptogen
hepat
southwestern
china
howev
hypothesi
confirm
antibodi
studi
japan
hanta
virus
howev
may
still
play
role
hanta
viru
infect
observ
trigger
autoimmun
liver
diseas
yotsuyanagi
et
al
thu
mechan
may
contribut
communityacquir
hepat
martin
et
al
nevertheless
precis
role
hanta
viru
infect
human
liver
diseas
still
await
clarif
time
symptom
evid
patient
uniformli
antivir
igm
antibodi
igg
antibodi
diagnost
assay
detect
hanta
viru
antibodi
includ
enzymelink
immunosorb
assay
elisa
immunoblot
test
sia
western
blot
indirect
immunofluoresc
ifa
complement
fixat
hemagglutinin
inhibit
well
neutral
assay
hanta
viru
strain
associ
hemorrhag
fever
hepatoren
syndrom
sensit
ribavirin
vitro
prospect
random
doubleblind
placebocontrol
trial
peopl
republ
china
report
sevenfold
decreas
mortal
among
ribavirintr
patient
serolog
confirm
hanta
viru
diseas
huggin
et
al
howev
ribavirin
appear
less
effect
hanta
viru
cardiopulmonari
syndrom
thu
yet
approv
nevertheless
may
tri
rescu
treatment
emerg
situat
sidwel
smee
yellow
fever
member
flavivirida
famili
constitut
singlestrand
plu
strand
rna
viru
compris
singl
conserv
serotyp
seven
major
genotyp
reflect
distinct
region
west
africa
centraleast
africa
south
america
vasconcelo
et
al
barnett
yellow
fever
viru
transmit
varieti
differ
aed
vector
caus
endem
epidem
outbreak
africa
south
america
yellow
fever
prevent
vaccin
thu
becom
rare
travel
spectrum
yellow
fever
viru
infect
rang
subclin
infect
lifethreaten
diseas
fever
jaundic
renal
failur
hemorrhag
usual
yellow
fever
initi
present
acut
flulik
ill
sudden
onset
fever
myalgia
headach
distinguish
easili
acut
infect
sever
malaria
leptospirosi
fulmin
viral
hepat
dengu
hemorrhag
fever
h
onset
aminotransferas
start
rise
blood
herald
develop
jaundic
degre
liver
abnorm
stage
predict
sever
liver
diseas
cours
ill
later
next
period
appar
remiss
last
h
may
follow
initi
infect
patient
abort
infect
recov
stage
patient
enter
third
stage
intox
character
return
fever
prostrat
organ
dysfunct
patient
suffer
nausea
vomit
epigastr
pain
develop
jaundic
oliguria
bleed
occur
mouth
nose
eye
stomach
serum
aspart
transferas
ast
level
usual
exceed
alanin
transferas
alt
outcom
yellow
fever
infect
determin
second
week
onset
mani
patient
either
rapidli
recov
patient
progress
stage
intox
ultim
die
circulatori
shock
convalesc
may
associ
fatigu
sever
week
occasion
jaundic
elev
aminotransferas
may
persist
month
diagnosi
yellow
fever
confirm
demonstr
specif
igm
elisa
pcr
isol
viru
blood
polymeras
chain
reaction
pcr
test
blood
urin
detect
viru
earli
stage
diseas
later
stage
test
identifi
antibodi
recommend
liver
biopsi
avoid
due
high
risk
bleed
complic
current
specif
antivir
drug
treat
yellow
fever
specif
care
manag
dehydr
liver
kidney
failur
well
fever
improv
outcom
ribavirin
inhibit
yellow
fever
viru
vitro
howev
extrem
high
concentr
drug
need
achiev
vivo
recent
attempt
treat
liver
failur
result
yellow
fever
infect
high
urgenc
liver
transplant
song
et
al
howev
outcom
liver
transplant
mix
survivor
frequent
postop
bacteri
cytomegaloviru
infect
highli
activ
attenu
livevaccin
avail
induc
seroconvers
rate
provid
high
level
protect
due
potenti
risk
associ
live
viru
vaccin
children
age
month
pregnant
women
immunosuppress
individu
receiv
vaccin
subject
vaccin
allerg
egg
protein
infrequ
two
seriou
vaccinerel
complic
may
occur
form
enceph
term
yellow
feverassoci
neurotrop
diseas
syndrom
resembl
natur
infect
design
yellow
fever
vaccineassoci
viscerotrop
diseas
adenovirus
worldwid
distribut
caus
febril
diseas
serotyp
distinguish
subdivid
six
subgoup
f
typic
syndrom
compris
conjunct
upper
respiratori
tract
infect
pharyng
coryza
pneumonia
otiti
media
young
children
acut
diarrheal
ill
caus
subgroup
f
type
adenovirus
adenovirus
persist
human
tissu
prolong
period
garnett
et
al
caus
varieti
clinic
syndrom
immunocompromis
individu
includ
sever
hepat
kojaoghlanian
et
al
particular
transmiss
latent
adenoviru
donat
organ
risk
factor
adenovir
hepat
pediatr
liver
transplant
michael
et
al
adenovir
hepat
occur
congenit
acquir
immunodefici
syndrom
resembl
sever
necrot
hepat
associ
herp
simplex
viru
infect
patient
develop
extens
area
liver
cell
necrosi
fig
massiv
elev
aminotransferas
sever
coagulopathi
south
et
al
janner
et
al
krilov
et
al
ultim
outcom
may
fatal
liver
biopsi
specimen
may
reveal
typic
intranuclear
inclus
bodi
necrot
area
liver
biopsi
carri
extrem
high
bleed
risk
viral
isol
pcr
techniqu
help
identifi
caus
viral
strain
date
proven
therapi
vaccin
prevent
adenovir
hepat
exist
ribavirin
may
help
select
case
wulffraat
et
al
liver
damag
fatal
influenza
consid
immunemedi
high
cytokin
level
detect
muralikrishna
et
al
peiri
et
al
moreov
volunt
infect
experiment
intranas
influenza
transient
develop
elev
aminotransferas
polako
et
al
sinc
rise
liver
enzym
occur
pyrexia
settl
conclud
host
immun
respons
rather
viral
infect
caus
damag
liver
immun
mediat
liver
damag
may
also
caus
elev
aminotransferas
viral
respiratori
infect
respiratori
syncyti
viru
peiri
et
al
howev
cardiovascular
failur
hepat
ischemia
must
consid
altern
factor
patient
sever
respiratori
infect
fig
eisenhut
et
al
influenza
virus
repres
three
genera
orthomyxovirida
famili
gener
influenza
virus
associ
sever
diseas
human
influenza
virus
b
c
influenza
subdivid
respect
genet
variat
hemagglutinin
h
neuraminidas
n
gene
influenza
virus
commonli
caus
selflimit
acut
respiratori
infect
fever
rhinorrhea
sore
throat
occasion
gastrointestin
symptom
therefor
aminotransferas
monitor
routin
influenza
outbreak
howev
patient
pneumonia
derang
liver
function
test
gastrointestin
symptom
vomit
abdomin
pain
diarrhea
initi
present
yuen
wong
although
molecular
evid
viral
liver
diseas
found
autopsi
reveal
hepat
centrolobular
necrosi
case
influenza
viru
infect
clinic
present
domin
fever
respiratori
symptom
diagnosi
establish
detect
viral
antigen
antibodi
nowaday
gold
standard
becom
detect
viral
rna
throat
wash
pcr
influenza
viru
infect
treat
prevent
neuraminidas
inhibitor
oseltamivir
zanamivir
recommend
especi
treatment
influenza
infect
et
al
howev
benefit
limit
due
appear
resist
isol
recent
outbreak
prevent
vaccin
adapt
annual
circul
strain
sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
sarscoronaviru
sarscov
caus
outbreak
sever
infect
lung
gastrointestin
tract
far
east
canada
ksiazek
et
al
drosten
et
al
lee
et
al
poutanen
et
al
also
organ
involv
middl
east
respiratori
syndrom
coronaviru
merscov
first
appear
arabian
peninsula
meanwhil
occasion
observ
also
travel
return
risk
area
apart
viral
pneumonia
intern
organ
may
becom
affect
includ
hepat
alsaad
et
al
particularli
merscov
hit
patient
concomit
diseas
exampl
diabet
mellitu
sarscov
merscov
detect
mask
palm
civet
dog
cat
well
camel
thu
repres
zoonot
infect
man
approxim
patient
sar
elev
liver
enzym
onset
infect
patient
normal
liver
enzym
initi
present
develop
elev
aminotransferas
later
overal
patient
show
elev
liver
enzym
ill
booth
et
al
choi
et
al
wong
et
al
chan
et
al
jaundic
observ
case
patient
aminotransferas
start
rise
toward
end
first
week
peak
end
second
week
resolut
sar
aminotransferas
normal
spontan
major
patient
sever
liver
damag
alt
time
upper
limit
normal
observ
frequent
male
patient
signific
comorbid
elev
serum
creatinin
level
chan
et
al
diagnosi
sarscov
merscov
infect
suspect
person
typic
symptom
contact
risk
area
diagnosi
confirm
certifi
special
microbiolog
lab
pcr
respiratori
fluid
hygien
prevent
measur
respect
handl
sampl
care
patient
suspect
coronaviru
pneumonia
sar
outbreak
ribavirin
kaletra
babi
dose
ritonavirlopinavir
test
experiment
therapi
show
limit
success
herpesvirus
form
larg
famili
dna
virus
compris
eight
member
caus
diseas
man
tabl
herp
simplex
viru
hsv
varizella
zoster
viru
vzv
epsteinbarr
viru
ebv
cytomegaloviru
cmv
human
herpesviru
type
directli
affect
liver
infect
human
popul
usual
acquir
childhood
adolesc
transmit
sexual
presum
also
vertic
mother
child
limit
preval
sever
immunosuppress
patient
caus
kaposi
sarcoma
bodi
caviti
lymphoma
herpesvirus
persist
lifelong
reactiv
liver
diseas
immunosuppress
patient
later
primari
herp
simplex
infect
produc
characterist
oral
genit
vesicular
lesion
symptom
sever
fever
malais
primari
infect
frequent
asymptomat
fulmin
hepat
complic
infect
pinna
et
al
organ
transplant
treatment
hematolog
malign
frequent
underli
predisposit
johnson
et
al
individu
risk
includ
neonat
patient
steroid
hivinfect
patient
patient
cancer
myelodysplast
syndrom
pinna
et
al
johnson
et
al
kusn
et
al
zimmerli
et
al
frederick
et
al
rare
fatal
hsvhepat
also
report
immunocompet
adult
goodman
et
al
varicella
zoster
viru
herpesviru
type
caus
chicken
pox
shingl
latent
infect
reactiv
primari
infect
replic
varicella
zoster
viru
epithelia
gut
respiratori
tract
liver
endocrin
gland
secondari
viraemia
lead
infect
skin
caus
typic
rash
liver
diseas
rare
limit
patient
sever
immunodefici
hsvrelat
hepat
high
mortal
resembl
septic
endotox
shock
jaundic
alway
present
kusn
et
al
patient
suffer
fever
anorexia
nausea
vomit
abdomin
pain
leucopenia
coagulopathi
typic
oral
genit
vesicular
lesion
may
present
patient
pinna
et
al
patient
dissemin
extrahepat
involv
exampl
lung
lymphnod
spleen
adren
gland
sever
varicella
zoster
viru
infect
hepat
lesion
similar
herp
simplex
hepat
varicella
zoster
viru
also
report
trigger
sever
autoimmun
type
hepat
alhoamoudi
diagnosi
hsvrelat
hepat
must
rapidli
establish
serolog
assay
littl
use
herp
simplex
varicella
zoster
virus
detect
preferenti
polymeras
chain
reaction
et
al
occasion
viral
isol
immunofluoresc
stain
prompt
system
treatment
acyclovir
reduc
hsvassoci
morbid
seriou
complic
hivinfect
patient
antivir
acyclovir
prophylaxi
markedli
reduc
hsv
reactiv
organ
transplant
seal
et
al
pettersson
et
al
acyclovir
resist
occur
immunocompromis
patient
neglig
immunocompet
subject
tyre
et
al
valacyclovir
prodrug
acyclovir
famciclovir
prodrug
penciclovir
similar
antivir
mechan
acyclovir
thu
hsv
isol
resist
acyclovir
also
resist
drug
levin
et
al
cidofovir
foscarnet
altern
choic
treat
acyclovirresist
hsv
less
well
toler
safrin
et
al
treatment
prophylaxi
varicella
zoster
hepat
similar
herp
simplex
virus
acyclovir
also
inhibit
replic
varicella
zoster
viru
immunocompet
host
cytomegaloviru
cmv
infect
may
rather
asymptomat
occasion
caus
transient
minim
symptomat
acut
diseas
congenit
cytomegaloviru
infect
occur
newborn
encount
kylat
et
al
newborn
immunocompromis
patient
exampl
hiv
infect
cancer
solid
organ
bone
marrow
transplant
becom
cmvinfect
may
develop
seriou
diseas
cmvrelat
liver
diseas
repres
commonest
caus
viral
hepat
organ
transplant
infect
may
result
reactiv
endogen
viru
immunosuppress
infect
transplant
organ
blood
transfus
cmvposit
donor
liver
transplant
cmv
diseas
occur
month
transplant
cmv
infect
also
potenti
factor
trigger
acut
chronic
reject
vice
versa
reject
therapi
corticosteroid
bolus
may
induc
endogen
cmv
reactiv
although
cmv
reactiv
frequent
complic
also
hivposit
patient
advanc
immunodefici
count
involv
liver
seem
rather
rare
palmer
et
al
cmv
occasion
caus
bileduct
necrosi
socal
hivcholangiopathi
scleros
cholang
encount
patient
termin
hivimmunodefici
bonacini
immunocompet
subject
primari
cytomegaloviru
infect
produc
infecti
mononucleosislik
syndrom
associ
elev
aminotransferas
mild
hepat
fig
liver
histolog
may
show
focal
hepatocyt
bile
duct
damag
lymphocyt
infiltr
sinusoid
occasion
epithelioid
granuloma
without
necrosi
cmv
inclus
bodi
cmv
immunostain
rare
seen
snover
horwitz
fetal
cmv
infect
also
associ
obstruct
biliari
diseas
neonat
hepat
giant
cell
transform
cholestasi
viral
inclus
bodi
finegold
carpent
liver
biopsi
hepatocyt
swollen
may
contain
basophil
granul
cytoplasm
typic
intranuclear
amphophil
inclus
bodi
present
resembl
owl
eye
fig
nuclear
cytoplasm
inclus
full
virion
desmet
howev
posttransplant
cmv
hepat
cytomegaloviru
inclus
bodi
scanti
instead
small
foci
necrosi
inflamm
microabscess
may
present
fig
de
novo
appear
cmv
igm
antibodi
fourfold
rise
igg
antibodi
herald
cmv
infect
immunocompet
individu
howev
serolog
unreli
immunocompromis
patient
replac
quantit
molecular
dna
amplif
assay
humar
et
al
caliendo
et
al
meanwhil
transplant
center
perform
cmv
surveil
weekli
quantit
determin
cmv
dna
transplant
unit
organ
recipi
high
risk
acquir
cmv
diseas
receiv
immun
prophylaxi
cmvhyperimmun
antibodi
antivir
drug
paya
howev
cmv
infect
diseas
may
still
develop
cmv
hepat
treat
promptli
patient
immunodefici
intraven
ganciclovir
oral
valganciclovir
week
treatment
choic
drug
must
continu
reduc
dose
chemoprophylaxi
prolong
immunosuppress
anticip
crumpack
fortun
ganciclovir
resist
still
rare
martin
et
al
toxic
altern
cidofovir
foscarnet
rare
need
epsteinbarr
viru
ebv
shed
oral
secret
primari
ebv
infect
occur
adolesc
ebv
account
acut
infecti
mononucleosi
syndrom
persist
lifelong
latent
state
result
dynam
interplay
viral
evas
strategi
host
immun
respons
whileunlik
herpesvirusesebv
reactivationassoci
liver
diseas
promin
featur
persist
ebv
infect
herpesviru
potent
caus
variou
malign
band
cell
lymphoma
hodgkin
lymphoma
nasopharyng
carcinoma
ebv
also
associ
aggress
lymphoprolif
diseas
liver
transplant
ebv
intrauterin
infect
may
lead
divers
congenit
anomali
also
compris
biliari
atresia
goldberg
et
al
howev
pregnant
women
suscept
thu
intrauterin
ebv
infect
rare
infant
young
children
primari
infect
frequent
asymptomat
adult
result
infecti
mononucleosi
syndrom
patient
develop
malais
headach
lowgrad
fever
specif
symptom
pharyng
tonsil
swell
cervic
lymphnod
moder
highgrad
fever
occur
nausea
vomit
anorexia
frequent
find
mild
clinic
hepat
accompani
infecti
mononucleosi
approxim
patient
fig
splenomegali
found
half
patient
hepatomegali
jaundic
infrequ
find
patient
show
peripher
blood
lymphocytosi
characterist
larg
abnorm
lymphocyt
blood
smear
vast
major
patient
recov
week
fatigu
may
persist
sever
month
infect
ebv
infect
hepatocyt
lymphoid
tissu
thu
liver
damag
due
immunemedi
patholog
andwhen
except
donebiopsi
specimen
show
diffus
lymphocyt
infiltr
sinusoid
occasion
focal
apoptot
hepatocyt
fig
purtilo
sakamoto
moreov
ebvrel
immun
activ
lead
sever
complic
patient
xlink
lymphoprolif
diseas
xlp
caus
mutat
gene
x
chromosom
particularli
vulner
epsteinbarr
viru
may
suffer
fatal
infect
extens
liver
necrosi
seemay
et
al
patient
sever
immunodefici
lymphomatoid
granulomatosi
unusu
complic
epsteinbarr
viru
infect
lead
granuloma
format
multipl
organ
includ
liver
may
requir
interferonalpha
antivir
therapi
wilson
et
al
patient
hiv
infect
ebvassoci
lymphoprolif
disord
hepat
infiltr
immunoblast
beissner
et
al
hemophagocyt
syndrom
report
albrecht
et
al
epsteinbarr
viru
also
major
caus
agent
socal
posttranspl
lymphoprolif
diseas
ptld
organ
transplant
may
result
lymphocyt
infiltr
liver
organ
rang
benign
polyclon
b
cell
prolifer
malign
b
cell
lymphoma
hanto
ptld
occur
commonli
children
adult
depend
degre
immunosuppress
primarili
complic
ebvneg
organ
recipi
develop
primari
ebv
infect
immunosuppress
owe
graft
ebvposit
donor
final
ebv
potent
risk
factor
develop
lymphoma
later
life
even
patient
without
overt
immunosuppress
fig
clinic
suspicion
epsteinbarr
viru
infect
confirm
detect
heterophil
ebvspecif
antibodi
infecti
mononucleosi
quantit
polymeras
chain
reaction
assay
patient
lymphoprolif
disord
bruu
et
al
weinberg
et
al
liver
biopsi
recommend
routin
diagnost
treatment
epsteinbarr
viru
infect
primarili
support
corticosteroid
therapi
amelior
symptom
howev
option
consid
individu
immunemedi
lifethreaten
complic
exampl
immin
liver
failur
theoret
concern
suppress
immun
system
infect
potenti
oncogen
viru
corticosteroid
recommend
gener
acyclovir
inhibit
ebv
dna
polymeras
antivir
therapi
drug
shorten
viru
shed
fail
demonstr
convinc
clinic
benefit
even
sever
acut
epsteinbarr
viru
infect
torr
tambini
acyclovir
antivir
therapi
effect
latent
ebvinfect
thu
reduct
immunosuppress
anticanc
chemotherapi
bcell
deplet
antibodi
need
treat
ebvrel
lymphoprolif
disord
human
herpesvirus
type
exist
two
variant
infect
cell
variou
cell
type
express
receptor
santoro
et
al
although
genet
clearli
distinct
anoth
bherpesviru
share
mani
featur
primari
infect
either
viru
commonli
occur
young
age
lead
febril
ill
known
exanthema
subitum
roseola
infantum
leach
pityriasi
rosea
reflect
primari
infect
also
integr
host
genom
transmit
via
germlin
reactiv
tanakataya
et
al
well
cytomegaloviru
lead
symptomat
cmvdiseas
liver
transplant
humar
et
al
full
spectrum
diseas
caus
chronic
infect
still
unclear
virus
put
involv
varieti
differ
syndrom
enceph
multipl
sclerosi
pneumon
infecti
mononucleosislik
syndrom
postinfecti
drug
hypersensit
well
lymphoprolif
disord
system
diseas
immunocompromis
patient
stoeckl
caus
sever
fatal
hepat
neonat
children
adult
mendel
et
al
chevret
et
al
et
al
hepat
due
infect
reactiv
also
complic
organ
transplant
dockrel
paya
et
al
ohashi
et
al
addit
associ
autoimmun
giantcel
hepat
giantcel
transform
bile
duct
cell
potenza
et
al
antibodi
develop
within
week
infect
unreli
marker
falseposit
test
result
healthi
control
beyond
serolog
distinguish
variant
may
crossreact
prefer
method
diagnos
infect
quantit
dna
amplif
assay
deback
et
al
detect
high
viral
load
liver
specimen
viremia
associ
approxim
twofold
increas
mortal
liver
transplant
pischk
et
al
immunocompet
patient
caus
benign
selflimit
infect
requir
specif
antivir
treatment
unlik
rel
resist
ganciclovir
foscarnet
act
three
virus
yoshida
et
al
de
clercq
et
al
cidofovir
may
therapeut
altern
resist
isol
identifi
bonnaf
et
al
human
herpesviru
gherpesviru
potenti
malign
transform
although
primari
infect
caus
rash
fever
children
immunocompromis
individu
onset
diseas
usual
occur
sever
year
acquisit
kaposi
sarcoma
bodi
caviti
lymphoma
multicentr
castleman
diseas
typic
present
infect
bone
marrow
aplasia
multipl
myeloma
also
describ
associ
infect
lee
henderson
autopsi
studi
kaposi
sarcoma
involv
liver
approxim
patient
aid
usual
part
widespread
cutan
viscer
diseas
due
highli
activ
antiretrovir
combin
therapi
kaposi
sarcoma
becom
rare
complic
hiv
infect
howev
fulmin
hepat
kaposi
sarcoma
may
occur
organ
transplant
cahoon
et
al
fig
macroscop
darkr
tumor
skin
liver
capsul
parenchyma
microscop
typic
lesion
mesh
spindlecelllik
tumor
cell
dilat
thinwal
vessel
glasgow
et
al
hepatosplenomegali
fever
weight
loss
typic
featur
multicentr
castleman
diseas
premalign
prolifer
blymphocyt
fig
lymphocyt
multicentr
castleman
diseas
kaposi
sarcoma
seem
cooper
thu
two
lesion
occasion
occur
within
lymphnod
naresh
et
al
ascit
pleural
effus
hallmark
bodi
caviti
lymphoma
possibl
give
rise
fals
initi
diagnosi
decompens
liver
cirrhosi
howev
abund
lymphoma
cell
aspir
fluid
provid
pivot
diagnost
hint
fig
also
caus
solid
organ
lymphoma
involv
liver
cesarman
knowl
diagnosi
associ
malign
establish
biopsi
via
characterist
histopatholog
featur
viru
detect
variou
antibodi
assay
polymeras
chain
reaction
pcr
assay
chiereghin
et
al
reconstitut
immun
function
primari
goal
treatment
associ
diseas
achiev
highli
activ
antiretrovir
therapi
hiv
infect
altern
antiprolifer
mtor
mammalian
target
rapamycin
inhibitor
immun
suppress
transplant
barozzi
et
al
immun
stimul
imiquimod
interferonalpha
babel
et
al
van
der
end
et
al
attempt
oncolog
therapi
liposom
anthracyclin
paclitaxel
kaposi
sarcoma
di
trolio
et
al
steb
et
al
rituximab
case
castleman
diseas
lymphoma
potent
treatment
option
bower
et
al
ganciclovir
cidofovir
foscarnet
adefovir
lobucavir
acyclovir
block
replic
vitro
control
crossov
trial
valganciclovir
reduc
oropharyng
shed
casper
et
al
overview
address
current
relev
viral
infect
involv
liver
howev
provid
outlin
far
exhaust
rare
instanc
hepat
occur
context
infect
enterovirus
sun
smith
measl
khatib
et
al
rubella
virus
mclellan
gleiner
well
parvoviru
yoto
et
al
hayakawa
et
al
reader
find
detail
rare
infect
microbiolog
textbook
beyond
intern
travel
global
warm
like
introduc
new
exot
infect
must
consid
differenti
diagnosi
sever
hepat
problem
illustr
recent
autochthon
crimeancongo
hemorrhag
fever
cchf
viru
infect
spain
negredo
et
al
occur
countri
thu
hepatologist
must
constantli
prepar
face
new
challeng
